ArticleNature communications2026

B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities.

Jian Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.